Healthcare >> CEO Interviews >> March 20, 2003

Gregory Weaver – Nastech Pharmaceutical Company Inc

GREGORY L. WEAVER is Chief Financial Officer of Nastech Pharmaceutical Company Inc. Prior to joining Nastech in May 2002, Mr. Weaver held the positions of Vice President, Strategic Development, and Vice President and Chief Financial Officer of Ilex Oncology, Inc., an oncology-focused biopharmaceutical company. Prior to Ilex, Mr. Weaver held several senior financial management positions, including Vice President and Chief Financial Officer of Prism Technologies, a medical device company, and Chief Financial Officer of a division of Fidelity Capital-Newspaper Publishing. Mr. Weaver received a Master of Business Administration degree in Finance from Boston College and a Bachelor of Science degree in Accounting from Trinity University in San Antonio. He also served in the United States Air Force. He is a Certified Public Accountant. Profile
TWST: Could we begin with a brief historical sketch of Nastech

and a picture of the things that are happening now?

Mr. Weaver: Nastech Pharmaceutical Company has a history of nasal

drug